Sign Up to like & get
recommendations!
0
Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf201.0209
Abstract: Leptomeningeal metastatic disease (LMD) literature has had extremely limited head-to-head comparison of available therapies, including systemic chemotherapy (SysCT), intrathecal (IT) or intraventricular therapy (ITV), whole-brain radiotherapy (WBRT), or cranio-spinal irradiation (CSI). No network meta-analysis (NMA)…
read more here.
Keywords:
disease lmd;
itv;
analysis;
metastatic disease ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2025 at "Neuro-Oncology"
DOI: 10.1093/neuonc/noaf201.0944
Abstract: Leptomeningeal disease (LMD) is a dreadful complication from cancer and its incidence is uprising with improved patient survivals from expanding therapies and diagnostic studies. There are no approved treatments for patients with LMD and the…
read more here.
Keywords:
disease lmd;
leptomeningeal disease;
cancer;
program ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.800053
Abstract: Leptomeningeal disease (LMD) is a devastating category of CNS metastasis with a very poor prognosis and limited treatment options. With maximal aggressive therapy, survival times remain short and, without treatment, prognosis is measured in weeks.…
read more here.
Keywords:
oncology;
diagnosis treatment;
disease lmd;
leptomeningeal disease ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2023 at "Cancers"
DOI: 10.3390/cancers15061884
Abstract: Simple Summary Leptomeningeal disease in melanoma (LMM) patients is characterized by aggressiveness and dismal outcomes. Clinical studies and case reports demonstrate the potential of immune and targeted therapies (especially in combinatorial or multi-modal settings) in…
read more here.
Keywords:
melanoma;
disease lmd;
lmd;
leptomeningeal disease ... See more keywords